Alpha-blocking properties of idazoxan (170150 or RX 781094) and its stereoisomers: applications to bronchomotricity.
The alpha 1- and alpha 2-adrenolytic properties of idazoxan and its stereoisomers were studied on the bronchopulmonary system of unanaesthetized guinea-pigs by testing the effects of these compounds on the phenylephrine-acetylcholine and clonidine-acetylcholine interactions. Idazoxan and its (+) and (-) stereoisomers did not significantly modify the protection exerted by phenylephrine against acetylcholine modify the protection exerted by phenylephrine against acetylcholine (ACh)-induced bronchoconstriction. Idazoxan and its (+) and (-) stereoisomers reduced the potentiation of ACh bronchoconstriction induced by clonidine, but (+) idazoxan was more potent than (-) and (+/-) idazoxan. As (+) idazoxan appeared to be a preferential alpha 2 central adrenoceptor blocking agent, these results seem to indicate that the site of action of clonidine in bronchomotor responses is the central nervous system.